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Herbaspirillum species, an organism commonly found in soil, has only recently been linked to disease in
humans. We report Herbaspirillum bacteremia in a 2-year-old female patient following a hematopoietic stem
cell transplant for relapsed acute lymphoblastic leukemia.
CASE REPORT
We report the case of a 2-year-old female diagnosed with
acute lymphoblastic leukemia (ALL) classified as high-risk
due to MLL gene rearrangement. A double-lumen Broviac
catheter was placed for intravascular access. The child went
into clinical remission after standard five-drug induction
chemotherapy, but cytogenetic analysis of her bone marrow
following induction revealed the presence of persistent leu-
kemic cells, conferring a risk for relapse. As a result, she
underwent a matched, unrelated donor hematopoietic stem
cell transplant (MUD HSCT). The child’s course of treat-
ment was uncomplicated until posttransplant day 162, when
she was admitted with a 2-day history of fever (maximum
temperature, 103.5°F) and diarrhea. She presented to her
local hospital emergency room, where she was found to be
tachycardic and febrile. She received two intravenous nor-
mal saline fluid boluses and was empirically started on
ceftriaxone (50 mg/kg of body weight) prior to transfer to
our hospital.
On admission, the patient was hemodynamically stable,
with an unremarkable physical examination. Admission lab-
oratory results included a white blood cell (WBC) count of
3,400/mm3, with 83% neutrophils, 1% bands, 11% lympho-
cytes, 5% monocytes, an absolute neutrophil count of 2,822,
and a hemoglobin level of 9.5 g/dl. She was empirically
started on cefepime (50 mg/kg) administered every 8 h.
Given the history of diarrhea, stool was sent for enteric
culture and Clostridium difficile toxin testing. These studies
were negative, and the child’s diarrhea resolved spontane-
ously on admission.
Isolator blood cultures were drawn on admission from
both the red and the white central venous line lumens, and
within 36 h, the quantity (CFU/ml) of a long, thin, oxidase-
positive, weakly catalase-positive, Gram-negative bacillus
was too numerous to count. At this point, gentamicin (2.5
mg/kg/dose every 8 h) was added to the antibiotic therapy.
Two days later, an Isolator blood culture from the white
lumen was still growing the same organism in a quantity too
numerous to count, while 39 CFU/ml was recovered from the
red lumen. Blood cultures drawn on the third day from both
central venous line lumens and a peripheral site were sterile.
Antibiotic therapy was changed to meropenem at a dose of 20
mg/kg every 8 h for a total of 7 days following the negative
blood culture.
The Vitek 2 Gram-negative identification system identified
the organism as Burkholderia cepacia complex. The corre-
sponding Kirby-Bauer disk diffusion susceptibility testing
showed that the isolate was colistin resistant (consistent with B.
cepacia) but susceptible to piperacillin-tazobactam, ticarcillin-
clavulanic acid, trimethoprim-sulfamethoxazole, meropenem,
ceftazidime, gentamicin, amikacin, tobramycin, ciprofloxacin,
and cefepime—a susceptibility pattern not consistent with that
of B. cepacia. The isolate was then inoculated onto (i) the
Remel Uni-N/F Tek plate for identification of oxidase-positive,
nonfermenting Gram-negative bacilli, (ii) oxidation-fermenta-
tion polymyxin B-bacitracin-lactose (OFPBL) agar, and (iii)
the BD Phoenix Gram-negative identification panel. The
Phoenix panel identified the isolate as Cupriavidus pauculus
and then on repeat testing as Ochrobactrum anthropi. The
Uni-N/F Tek plate was positive for xylose, mannitol, urease,
and o-nitrophenyl--D-galactopyranoside (ONPG). It was neg-
ative for hydrogen sulfide production, lactose, maltose, acet-
amide, esculin, DNase, and indole. The isolate was nonpig-
mented. The combination of the susceptibility pattern and the
biochemical reactions was not compatible with any of the au-
tomated identifications.
DNA was extracted from a pure culture of the isolate using
the BiOstic bacteremia DNA isolation kit (MoBio Laborato-
ries, Inc., Carlsbad, CA). Amplification of the 16S rRNA gene
was performed using the primers 27F (AGA GTT TGA TCC
TGG CTC AG) and 1391R (GAC GGG CGG TGW GTR
CA), and the product was sequenced (5). The sequence was
compared with the GenBank “nr/nt” database and the Ribo-
somal Database Project and had 99.9% identity (742/743
nucleotides) with Herbaspirillum spp. The next-closest match
was Ralstonia spp., with 97.0% sequence homology (720/743
nucleotides) to our isolate. The biochemical features of our
isolate were consistent with what has been previously described
for Herbaspirillum spp., namely, being oxidase positive and
weakly catalase positive, in addition to being ONPG and ure-
ase positive (6, 7).
The patient’s central venous line was removed prior to dis-
charge and was not replaced, as this was her third line infection
in 6 months, and it was almost 180 days after her stem cell
infusion. The organisms associated with the previous infections
were Pseudomonas putida, coagulase-negative Staphylococcus
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spp., and Candida parapsilosis, all of which were isolated 5
months prior to this admission.
Given the myeloablative effects of the conditioning regimen
prior to stem cell infusion, followed by the chronic administra-
tion of immunosuppressive therapy to minimize the chance of
rejection, recipients of MUD HSCT are immunosuppressed
for at least 1 year posttransplantation. In addition to being
immunosuppressed, patients may have indwelling catheters in
place during this time. While a wide spectrum of organisms,
including those causing opportunistic infections, are known to
cause disease in this population, Herbaspirillum species has not
been previously reported.
Herbaspirillum species was first described about 25 years ago
(1, 6) as a Gram-negative, rod-shaped member of the Beta-
proteobacteria class. It is a nitrogen-fixing soil and plant bacte-
rium previously not considered a human pathogen (1, 3). Its
close phylogenetic and phenotypic resemblance to Burkhold-
eria cepacia complex has often resulted in misidentification (2,
4). Although one of the earliest documented human infections
with this organism was reported in 2005 from a wound isolate
in a 49-year-old homeless man with a history of chronic liver
disease (8), the advent of new technology has led to the re-
classification as Herbaspirillum of previously identified and
other, unclassified human isolates obtained as early as 1978
from infections of the ear, eye, knee, urine, oropharnyx, gas-
trointestinal tract, blood, and respiratory tract (2). Between
2000 and 2007, the Burkholderia cepacia Research Laboratory
and Repository at the University of Michigan, Ann Arbor,
isolated Herbaspirillum from 28 sputum cultures and one blood
isolate referred from 23 cystic fibrosis (CF) treatment centers
in the United States; 19 (68%) of the isolates had been initially
identified as Burkholderia (4). Recent theories about infections
contributing to aortic aneurysms led to the isolation of multiple
organisms, including Herbaspirillum species, from aneurismal
walls. Though this infectious etiology remains unproven, it is a
cause for great concern (5). In light of the fact that automated
systems will provide an identification for this organism (albeit
an incorrect one), it is possible that this organism may be an
underrecognized cause of opportunistic infection.
Although stem cell transplant recipients are prone to a wide
spectrum of infections, Herbaspirillum species has not been
previously described as a cause of infection in this patient
population. It is uncertain how our patient was exposed to this
soil-based organism, but she lives with her parents and grand-
parents on a large farm, and we speculate that she likely en-
countered the organism in that environment.
This case demonstrates the utility of sequence-based iden-
tification of organisms, especially those that are not in the
databases of commercial identification systems or are not
readily identifiable using conventional phenotypic method-
ology.
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